Afuco™ Anti-NRP1 ADCC Therapeutic Antibody (Vesencumab), ADCC Enhanced

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to NRP1. Vesencumab is an immunomodulator designed for the treatment of solid malignancies. It binds to neuropilin 1.
Supplier Creative Biolabs
Product # AFC-TAB-264
Pricing Inquiry
Host Human
Target NRP1
Species Reactivity Human
Type ADCC enhanced antibody
Applications IP, IF, FuncS, FC, Neut, ELISA
Storage Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback